ReDS™: Providing Actionable Results in a World of Uncertainty
Stories abound across the Internet of earthquake survivors living weeks or even months trapped in the ruins of buildings. When an earthquake struck Haiti in 2010 and killed at least 200,000 people, a man survived trapped in the rubble for almost two weeks in the ruins of a store repeatedly visited by looters. That’s one week longer than the typical UN search and rescue mission. Even amidst these inspiring stories of survival, though, the fact remains: every moment is critical in finding survivors before time runs out. There is no time for guesswork.
However, finding survivors is something like looking for the proverbial needle in a haystack. To help with this, the military developed and has come to rely upon technology allowing rescuers to see through walls to find these survivors and to accurately pinpoint their location within the rubble. This technology saves time, and lives, by removing guesswork.
HF in the United States Today
In the United States, today, approximately 5.7 million adults live with HF – and the costs related to their care reach some $30.7 billion annually. Roughly half of these costs come from the constant discharges and readmissions of HF patients who lack a sufficient device to assess their lung fluid measurements. If patients wait for symptoms like shortness of breath or fatigue to show up, the fluids in their lungs have often progressed to the point that they already require medical attention.
Clearly, there remains some guesswork in determining when, and if, patients need to go to the hospital for their condition. That’s concerning – first, from the health and well-being perspective of an incorrect decision being made, and second, from the economic perspective of the costs incurred due to these incorrect decisions.
ReDS™: Reducing Uncertainty in HF Care
When Sensible Medical set out to create a new standard of care in lung fluid measurement, we adapted the military’s see-through-wall technology in creating our ReDS™ system. With ReDS™, the HF patient just wears a non-invasive vest, with no leads or conductive agents required. The ReDS™ vest uses low-power electromagnetic energy to deliver accurate readings in just 90 seconds. By using accurate, real-time data, practitioners can make better, more informed decisions.
ReDS™: a Decision Support Tool, that Delivers Benefits
During a 2015 prospective, single-armed, economic benefit interventional feasibility study, ReDS™-guided management was found to decrease the amount of patient hospitalizations by 87%, when compared to the three-month pre–ReDS™ period.
ReDS™ can help in the:
- Outpatient clinic, by helping avoid hospitalizations through improving treatment titration and overall monitoring;
- Emergency Department, by helping avoid unnecessary hospitalizations through improving triage and decision support;
- CHF Ward, by helping evaluate patient readiness for discharge and avoiding rehospitalizations; and
- At the Nursing Home, by reducing admissions out of skilled nursing facilities (SNF).
Simply put, ReDS™ can help break the vicious cycle of unnecessary admissions into, and discharges out of, the hospital.
Creating Excitement in the Market
Since its introduction, the potential for ReDS™ to significantly improve HF patient management by increasing accuracy and confidence in lung fluid assessment has excited the health care market. Dr. William Abraham, MD, recently said, “We were looking for a technology that would be non-invasive yet offer accuracy. This search led us to ReDS™.”
If see-through-wall technology can save the lives of those trapped in the rubble of buildings, and improve the lives of those living with HF, that’s a win for everyone involved. With the benefits offered by ReDS™, everyone can rest easier that the care of HF patients just got better, and that a technology that can save lives, and unnecessary hospitalization costs, now exists on the market.
Source articles referenced while writing this article: